Elsevier

Magnetic Resonance Imaging

Volume 17, Issue 7, September 1999, Pages 1001-1010
Magnetic Resonance Imaging

Original Contribution
3D spin-lock imaging of human gliomas

https://doi.org/10.1016/S0730-725X(99)00041-7Get rights and content

Abstract

We investigated whether the simultaneous use of paramagnetic contrast medium and 3D on-resonance spin lock (SL) imaging could improve the contrast of enhancing brain tumors at 0.1 T. A phantom containing serial concentrations of gadopentetate dimeglumine (Gd-DTPA) in cross-linked bovine serum albumin (BSA) was imaged. Eleven patients with histologically verified glioma were also studied. T1-weighted 3D gradient echo images with and without SL pulse were acquired before and after a Gd-DTPA injection. SL effect, contrast, and contrast-to-noise ratio (CNR) were calculated for each patient. In the glioma patients, the SL effect was significantly smaller in the tumor than in the white and gray matter both before (p = 0.001, p = 0.025, respectively), and after contrast medium injection (p < 0.001, p < 0.001, respectively). On post-contrast images, SL imaging significantly improved tumor contrast (p = 0.001) whereas tumor CNR decreased slightly (p = 0.024). The combined use of SL imaging and paramagnetic Gd-DTPA contrast agent offers a modality for improving tumor contrast in magnetic resonance imaging (MRI) of enhancing brain tumors. 3D gradient echo SL imaging has also shown potential to increase tissue characterization properties of MR imaging of human gliomas.

Introduction

Gadolinium-based contrast agents are routinely used in clinical magnetic resonance (MR) imaging to increase the sensitivity and specificity of brain tumor studies.1, 2 Spin lock (SL), and magnetization transfer (MT) imaging are new techniques that have been shown to increase contrast-to-noise ratio (CNR) and improve tissue characterization in MR imaging.3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16 A significant improvement in contrast of brain lesions when the use of paramagnetic contrast material is combined with MT imaging has been demonstrated.17, 18, 19, 20, 21 The contrast improvement is due to the difference in the efficiency of MT in non-enhancing, macromolecular rich tissue and in enhancing tissue. MT is strong in macromolecular rich tissue but in enhancing tissue the paramagnetic relaxation reduces MT. It has been suggested that MT at low field strength is the main source of relaxation observed with the SL technique.22 Thus, combining T1-weighted SL imaging with the use of paramagnetic contrast material may improve the detection of enhancing brain tumors.

In an SL experiment the locked nuclear magnetization relaxes along the locking field (B1L) during the locking period (TL). The observed relaxation may be considered as longitudinal relaxation at B1L corresponding to the Larmor frequency f1L = (γ/2π) B1L. The strength of B1L is very low compared to the strength of the polarizing magnetic field (B0). Therefore, the observed relaxation time T, usually called longitudinal relaxation time in the rotating frame, probes the very low frequency range, and, therefore, is likely to be more sensitive to changes in concentration, mobility, and interactions of macromolecules than T1 obtained at B0. In the present study we have combined SL pulse and T1-weighted 3D imaging to evaluate the usefulness of imaging of human brain gliomas. For evaluating the T1-weighted 3D SL imaging, we used an appropriate phantom model containing different cross-linked bovine serum albumin (BSA) and gadopentetate dimeglumine (Gd-DTPA) concentrations.23 In the patient study we investigated whether the simultaneous use of paramagnetic contrast medium and T1-weighted SL imaging could improve the contrast of enhancing brain tumors.

Section snippets

Materials and methods

All imaging was performed at room temperature with a low field (B0 = 0.1 T) resistive magnet imager (Merit®, Picker Nordstar, Inc., Helsinki, Finland) using a head transmitting/receiving coil.

Phantom study

1/T and 1/T1 for all protein concentrations increased with increasing the Gd-DTPA concentration as shown in Fig. 2 (a and b). T1 relaxivity of Gd-DTPA in the 5, 10, 15, and 20% cross-linked BSA was 7.6 ± 0.2, 8.3 ± 0.2, 9.6 ± 0.2, and 9.8 ± 0.4 mmol−1 l s−1, respectively. T relaxivity of Gd-DTPA in the 5, 10, 15, and 20% cross-linked BSA was 6.9 ± 0.2, 7.6 ± 0.3, 9.4 ± 0.7, and 9.8 ± 0.9 mmol−1 l s−1, respectively. Both T1 and T relaxivities of Gd-DTPA increased slightly with increasing

Discussion

The combination of MT technique and contrast medium (Gd-DTPA) has been proven to improve contrast and CNR in brain lesion imaging.17, 18, 19, 20, 21 The SL technique combined with simultaneous use of paramagnetic contrast agents has also improved tissue contrast in previous studies.24, 25 Although Gd-DTPA reduced both relaxation times T1 and T (Fig. 2), increasing Gd-DTPA concentration did not have a significant effect on the measured SLeff on T1-weighted images in the phantom when we

Acknowledgements

We thank Peter B. Dean, M.D., for his comments on the manuscript. This work was supported in part by Magnus Ehrnrooth Foundation (U.A.R.), Alfred Kordelin Foundation (U.A.R.), HUCH-Foundation (U.A.R.), Radiological Society of Finland (U.A.R.), Cancer Organizations of Finland (H.J.A., A.T.M.), Vuorisalo Foundation (H.J.A.), Paulo Foundation (H.J.A.), Research grants from Helsinki University Central Hospital, and EVO grants TYH0068 and TYH8102 (H.J.A., U.A.R., A.T.M.).

References (26)

  • A. Virta et al.

    T imaging characteristics of human anterior tibial and gastrocnemius muscles

    Acad. Radiol.

    (1998)
  • A. Virta et al.

    Low field T imaging of myositis

    Magn. Reson. Imaging

    (1998)
  • R. Felix et al.

    Brain tumors: MR imaging with gadolinium-DTPA

    Radiology

    (1985)
  • B.W. Schwaighofer et al.

    Clinical experience with routine Gd-DTPA administration for MR imaging of the brain

    J. Comput. Assist. Tomogr.

    (1990)
  • N. Lundbom

    Determination of magnetization transfer contrast in tissue: An MR imaging study of brain tumors

    Am. J. Roentgenol.

    (1992)
  • J.M. Boorstein et al.

    Metastatic lesions of the brain: Imaging with magnetization transfer

    Radiology

    (1994)
  • D.M. Yousem et al.

    Head and neck neoplasms: Magnetization transfer analysis

    Radiology

    (1994)
  • G.E. Santyr et al.

    Spin locking for magnetic resonance imaging with application to human breast

    Magn. Reson. Med.

    (1989)
  • R.E. Sepponen

    Rotating frame and magnetization transfer

  • E. Rommel et al.

    T Dispersion imaging and localized T dispersion relaxometry: Application in vivo to mouse adenocarcinoma

    Magn. Reson. Med.

    (1992)
  • A.E. Lamminen et al.

    T dispersion imaging of diseased muscle tissue

    Br. J. Radiol.

    (1993)
  • J.T. Halavaara et al.

    Spin lock magnetic resonance imaging in the differentiation of hepatic heamangiomas and metastases

    Br. J. Radiol.

    (1995)
  • A.T. Markkola et al.

    Spin lock and magnetization transfer imaging of head and neck tumors

    Radiology

    (1996)
  • Cited by (53)

    • Biologically aggressive regions within glioblastoma identified by spin-lock contrast T1 relaxation in the rotating frame (T1ρ) MRI

      2017, Radiology Case Reports
      Citation Excerpt :

      To date, clinical applications of this MRI technique has been most widely applied to evaluating the hydration status of human articular cartilage. However, the neurologic applications of T1ρ MRI have been explored in patients with ischemia, neurodegenerative disorders, and brain tumors, and as a response assessment to gene therapy within glioma mouse models [12–23]. T1ρ MRI obtains tissue contrast through the quantification of spin-lattice relaxation in the rotating frame.

    • Differentiation of brain tumor-related edema based on 3D T1rho imaging

      2017, European Journal of Radiology
      Citation Excerpt :

      To the best of our knowledge, whole brain T1ρ imaging has not been previously used to characterize the pathological processes of untreated brain tumors and associated cerebral edema in humans. T1ρ has been studied to a limited extent in several neuroimaging applications including the evaluation of ischemia [11,23,24], neurodegenerative disorders [17,18], demyelinating disease [20,21], animal models of brain tumor [12–14,25], and response to gene therapy [15,16]. Although the exact mechanisms governing T1ρ relaxation are not fully understood, several factors proposed to influence T1ρ include scalar coupling, dipole–dipole interactions, and chemical exchange processes [26].

    • Artifacts correction for T1rho imaging with constant amplitude spin-lock

      2017, Journal of Magnetic Resonance
      Citation Excerpt :

      T1rho is often measured by the spin-lock technique described by Redfield [1] and was introduced into the field of MRI by Sepponen et al. [2]. It has been reported that T1rho imaging is potentially useful for diagnostic imaging of a variety of human diseases [3–14]. Conventional spin-lock is achieved by applying a radiofrequency (RF) pulse with constant amplitude along the magnetization after RF excitation.

    • T1rho MRI and CSF biomarkers in diagnosis of Alzheimer's disease

      2015, NeuroImage: Clinical
      Citation Excerpt :

      T1ρ MRI has been previously used to measure the T1ρ relaxation time in the normal human brain, and showed higher range of values compared to the T2 relaxation time (Borthakur et al., 2004). Earlier, T1ρ has been used to delineate brain tumors (Aronen et al., 1999), characterize breast cancer tissue (Li et al., 2011), and monitor the level of cartilage degeneration (Regatte et al., 2004; Witschey et al., 2010). Borthakur et al. have shown the feasibility of T1ρ imaging in evaluating the plaques burden in a mouse model of AD (Borthakur et al., 2006a).

    View all citing articles on Scopus
    View full text